2012 Final Brochure

Executive Sponsor

Premier Sponsor

2009 Course DVD

HCAE DVD
2009 High Content Analysis
Course

Mark your calendar for 2013

Tenth Annual High-Content Analysis
January 8-11, 2013
The Fairmont Hotel
San Francisco, California

Visit: www.highcontentanalysis.com often for program updates

High-Content Analysis 2012 feedback

“This is a fantastic meeting that definitely will change the way I do science in the coming years.”
James J., University of British Columbia

“An excellent opportunity to learn advanced methods of high-content analysis and engage new collaborations for those who develop technology or sell technology, and for end-users who want to adopt these technologies.”
Ray T., McMaster University

“The science was really ‘high in content.’ Meets and exceeds expectations. A must for beginners in HCS.”
Anurag V., Daiichi Sankyo

“As a newcomer to the high-content field, the HCA conference was incredibly helpful in learning the capabilities of cutting-edge instruments, assays, analysis algorithms, and data management solutions. The entire community was surprisingly forthcoming with pearls and pitfalls learned through experience that can often save months of assay development!”
Christopher H., Amgen

“No other single HCA meeting is able to capture the latest advancements in HCA as well as this one can, on all levels, from data analysis to groundbreaking image visualization techniques.”
Ralph G., Park Bioventures

“A must-attend for HCA users and providers!”
Sara D., Northwestern University

“The best HCA meeting of the year, covering all aspects of HCA and HCS.”
Marjo G., Novartis Institutes for BioMedical Research

Cambridge Healthtech Institute's High-Content Analysis 2012 (HCA) was held January 10-13, 2012 at the Fairmont Hotel in San Francisco, California

More than 350 people across Pharma, Biotechnology and Academia came together in San Francisco to discuss applications and technologies in the field of High-Content Analysis (HCA) and Screening. The event featured User group meetings and an advanced short course, as well as a co-located meeting on Live-Cell Imaging. Now in its tenth year, HCA continues to deliver the answers as well as the attendance. This year featured participants from 21 different countries, representing 182 different organizations with more than 20% of the attendance from Pharmaceutical companies. The event also featured a good networking blend of Scientists (60%) and Executives (20%). More than 40% of the particiants were decision makers.

We hope you make plans to join us in 2013

The most COMPREHENSIVE COVERAGE of HCA applications and technologies.

COVERAGE INCLUDES:

HCA for Toxicity Assessment and Drug Screening
High-Content Image Analysis and Data Management
HCA for Pathway Analysis and RNAi
HCA of Stem Cells, Tissues, and Whole Organisms
3-D Cell Models
Neuronal Imaging
High-Content Flow Cytometry
Novel Probes and Biosensors
High-Content Screening of Live Cells
FLIM-FRET
Miniaturization Approaches